Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
286 On Other Exchanges
Symbol
Exchange
286 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

common splendor internationa (286) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for COMMON SPLENDOR INTERNATIONA (286)

Related News

No related news articles were found.

common splendor internationa (286) Related Businessweek News

No Related Businessweek News Found

common splendor internationa (286) Details

Common Splendor International Health Industry Group Limited, an investment holding company, engages in health industry, and investment and finance activities in the People’s Republic of China and Hong Kong. The company operates through two segments, Health Industry, and Investment and Finance. It is also involved in the health management business, natural health food business, and advantage growth for children and teenagers business. The company also offers healthcare investment management, including investment/merger and acquisition/trust/provision of consultancy services in relation to healthcare business. It operates Guangzhou Centre that provides health management services, including functional medicine, sleep medicine, genetics, stress medicine, fitness, and the medical treatment in the form of membership, as well as sells medical equipment and material. In addition, it is involved in investing and financing activities. The company was formerly known as G-Prop (Holdings) Limited and changed its name to Common Splendor International Health Industry Group Limited in December 2013. The company was incorporated in 1990 and is based in Tsim Sha Tsui, Hong Kong. Common Splendor International Health Industry Group Limited is a subsidiary of Champion Dynasty Limited.

75 Employees
Last Reported Date: 04/21/15
Founded in 1990

common splendor internationa (286) Top Compensated Officers

Deputy Chairman and Chief Executive Officer
Total Annual Compensation: $1.6M
Chairman
Total Annual Compensation: $699.0K
Compensation as of Fiscal Year 2014.

common splendor internationa (286) Key Developments

Common Splendor International Health Industry Group Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

Common Splendor International Health Industry Group Limited reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the six months, the company reported revenue of HKD 138,318,000 against HKD 12,972,000 a year ago. Profit from operations was HKD 12,912,000 compared to loss from operations of HKD 10,000 a year ago. Profit before tax was HKD 12,912,000 against loss of HKD 12,000 a year ago. Profit for the period was HKD 10,863,000 against loss of HKD 381,000 a year ago. Profit for the period attributable to owners of the company was HKD 8,551,000 or 0.33 cents per diluted share against HKD 2,231,000 or 0.09 cents loss per diluted share a year ago. Net cash generated from operating activities was HKD 12,533,000 against net cash used in operating activities of HKD 20,518,000 a year ago. Net asset value per share attributable to owners of the company as at 30 June 2015 was 18.6 cents compared to 18.0 cents a year ago. The substantial increase in both revenue and gross profit for the Period was mainly attributable to the acquisition of health industry businesses in the second half of 2014 which has become the major source of revenue and gross profit of the Group. The increase in profit mainly came from the increase in revenue from the new businesses that gave an increase in gross profit of the increase in share of results of newly acquired Allad optometry associates; net off the increase in administrative expenses of and the decrease in fair value gain on investment properties.

Common Splendor International Health Industry Group Limited to Report First Half, 2015 Results on Aug 31, 2015

Common Splendor International Health Industry Group Limited announced that they will report first half, 2015 results on Aug 31, 2015

Common Splendor International Health Industry Group Limited, Board Meeting, Aug 31, 2015

Common Splendor International Health Industry Group Limited, Board Meeting, Aug 31, 2015. Agenda: To approve the interim results of the company and its subsidiaries for the six months ended June 30, 2015 and its publication; and to consider the payment of an interim dividend.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
286:HK $0.76 HKD 0.00

286 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 286.
View Industry Companies
 

Industry Analysis

286

Industry Average

Valuation 286 Industry Range
Price/Earnings 74.5x
Price/Sales 3.8x
Price/Book 4.0x
Price/Cash Flow 58.3x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COMMON SPLENDOR INTERNATIONA, please visit www.g-prop.com.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.